Whole Network Most Recent TOP10 Gene Therapy Microbiology Nanomedicine Stem Cells

« MedImmune Considers Sale... | Main | Stem Cell Research... »

Merck Licenses Coley Pharma's VaxImmune for $4 Million

Filed in archive Corporate and Industrial News by ruth on April 13, 2007

Merck & Co., Inc. has licensed Coley Pharmaceutical's VaxImmune(TM) vaccine adjuvant for an upfront license fee of $4 million, and milestone fess of up to $33 million plus royalties.

VaxImmune is a proprietary Toll-like receptor 9 (TLR9) agonist designed to induce both an enhanced antigen-specific antibody response and a natural killer T-cell immune response when used in combination with prophylactic (preventative) or therapeutic vaccines.

VaxImmune is currently under clinical trials for various cancer, infectious disease links

and biowarfare applications.

Source: Coley Pharmaceutical
Photo: TLR Therapeutics, Coley Pharmaceuticals

Permalink: Merck Licenses Coley Pharma's VaxImmune for $4 Million
Tags: merck license investment pharma vaximmune vaccine biotech coley vaximmune+million

Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/63383

Related Entries:

Merck Steps it Up - 05 June 2006

Merck Develops New Diabetes Treatment - 31 August 2006

Merck KGaA Licenses Glenmark Pharmaceuticals' DPPIV... - 17 October 2006

Merck's HPV Vaccine May Expand to Women Up to 45 Years Old - 08 November 2007

Vote for Merck Licenses Coley Pharma's VaxImmune for $4 Million:

Currently 9.67/10
1
2
3
4
5
6
7
8
9
10

Rating: 9.7 out of 3 vote(s) cast.

RSS	\| See all blog subscribe options
Google	\| What is RSS?
Yahoo!
Addthis
Bloglines
Newsletter

Check out our Sponsored Blogs!
The Mobile Technology Weblog

Contributors (Last 90 days)
Gloria Gamat (3)
Ruth Schaffer (33)
This site has 1194 entries and is powered by Creative Weblogging since July 2005.
Do you want to start or edit an existing blog for us and get paid? More info.
Do you want to advertise on this blog? We have great ideas!
Do you have tips for us? Send them!

Advertise with us
Learn more about our advertising options or email advertising - at - creative-weblogging.com or give Luis a call at +1 (650) 331 8047.

Try the new biotech-wiki.com

Testimonials
'Very nice blog layout with great content. Are you interested in Star Trek props that are quickly becoming reality? Then this is the blog for you. Human medical scanners, nano technology and more great technological advancements.' -VirtualLoop Blog of the Week

'I subscribe to your blog and have been enjoying your posts and perspective.'

Other blogs in the same channel in the Creative Weblogging Network

Disclaimer
Some of the contents of this site are protected Creative Weblogging Ltd. 2004-2008.

Add your response to Merck Licenses Coley Pharma's VaxImmune for $4 Million:
Name: *	Email: (will never be shown)*	URL:

(* marked fields are required)
Notify me if more comments appear?	Subscribe to The Biotech Weblog newsletter? (Newsletters are sent out weekly).	Remember me
Security Code: * (Please help us to sort out spam.)

Please enter your comment here: (Sorry, no HTML is allowed - URLs will be made clickable automatically if you add http:// to your URL.)


We welcome your comments, however all comments are moderated. Offensive or off-topic comments will be deleted and not displayed.

Tell a friend about Merck Licenses Coley Pharma's VaxImmune for $4 Million
Recipient email:*	Your email:*

(* Both email addresses are required for sending this article. They will never be shown or used for any marketing purposes)
Please enter a message which will be shown together with the article:

Security Code: (Please help us to sort out spam.)

Merck Licenses Coley Pharma's VaxImmune for $4 Million

Filed in archive Corporate and Industrial News by ruth on April 13, 2007

Related Entries:

Vote for Merck Licenses Coley Pharma's VaxImmune for $4 Million:

Add your response to Merck Licenses Coley Pharma's VaxImmune for $4 Million:

Tell a friend about Merck Licenses Coley Pharma's VaxImmune for $4 Million

Check out our Sponsored Blogs!

Our Editors recommend

Contributors (Last 90 days)

Categories

Archives

Advertise with us

Most popular

Testimonials

Recent Comments

Other blogs in the same channel in the Creative Weblogging Network

Life Sciences

Disclaimer

Find more recent entries from our other publications:

Allergies

Straightfromthedoc

Daily Diabetic

The Flyaway Weblog

The Hedge Funds Weblog

On Storage